0

DEA Has Scheduled Synthetic Alkaloid Products as Schedule 1 Substance

Skip to Content

Advocacy

Restricted Zip Codes

Congressional Letter to FDA

GKC Letter to FDA

Leaf Kratom Regulation Map - USA

Louisiana Poll on Leaf Kratom Regulation

FDA’s Concentrated 7-OH Product Crackdown

Florida 7-OH Crackdown

KCAC's Advocacy Buddy

GKC For Consumers

The Evolution of Leaf Kratom Infographic

Marketing Guidelines

Florida FAQ Flyer

Regulatory Label Requirement

Novel Synthetic Alkaloid Database

About Us

Tax Status

Contact Us

Sign Up To Our Email List

AHP Botanical Safety Handbook

Scientists' Statement

Safety

Relative Safety/Risk Report: Kratom vs. Other Substances

GKC Statement on 7-Hydroxymitragynine Products

Scientists Statement on 7-OH MGPI Products

SUD Report: Prevalence, Severity and Symptom Endorsement

The Severity and Prevalence of Addictive Substances

Kratom Alkaloids

FDA Study on Kratom Dosing and Safety

National Marketing Institute (NMI) Kratom Survey

UCONN Continuing Education Program

"7" Fact vs. Fiction

Eight-Factor Analysis of Natural Kratom Leaf

Rise in Poison Center Calls are From Concentrated 7-OH: Data

North Dakota Poison Control Data 2021-2025

18 Human Clinical Trials

Kratom Science Is Accelerating. Fast.

Dr. Andrew Huberman - The Distinction

Kratom in Clinical Practice

In the News

Advocacy Buddy

About KCAC

KCAC Board Members

KCAC Position Statements

KCAC In The News

UConn Pharmacy Research on Kratom and Substances of Abuse

KCAC 2025 Impact Snapshot

Eight-Factor Analysis of Natural Kratom Leaf

Advocacy

Restricted Zip Codes

Congressional Letter to FDA

GKC Letter to FDA

Leaf Kratom Regulation Map - USA

Louisiana Poll on Leaf Kratom Regulation

FDA’s Concentrated 7-OH Product Crackdown

Florida 7-OH Crackdown

KCAC's Advocacy Buddy

GKC For Consumers

The Evolution of Leaf Kratom Infographic

Marketing Guidelines

Florida FAQ Flyer

Regulatory Label Requirement

Novel Synthetic Alkaloid Database

About Us

Tax Status

Contact Us

Sign Up To Our Email List

AHP Botanical Safety Handbook

Scientists' Statement

Safety

Relative Safety/Risk Report: Kratom vs. Other Substances

GKC Statement on 7-Hydroxymitragynine Products

Scientists Statement on 7-OH MGPI Products

SUD Report: Prevalence, Severity and Symptom Endorsement

The Severity and Prevalence of Addictive Substances

Kratom Alkaloids

FDA Study on Kratom Dosing and Safety

National Marketing Institute (NMI) Kratom Survey

UCONN Continuing Education Program

"7" Fact vs. Fiction

Eight-Factor Analysis of Natural Kratom Leaf

Rise in Poison Center Calls are From Concentrated 7-OH: Data

North Dakota Poison Control Data 2021-2025

18 Human Clinical Trials

Kratom Science Is Accelerating. Fast.

Dr. Andrew Huberman - The Distinction

Kratom in Clinical Practice

In the News

Advocacy Buddy

About KCAC

KCAC Board Members

KCAC Position Statements

KCAC In The News

UConn Pharmacy Research on Kratom and Substances of Abuse

KCAC 2025 Impact Snapshot

Eight-Factor Analysis of Natural Kratom Leaf

Folder: Advocacy

Back

Advocacy

Restricted Zip Codes

Congressional Letter to FDA

GKC Letter to FDA

Leaf Kratom Regulation Map - USA

Louisiana Poll on Leaf Kratom Regulation

FDA’s Concentrated 7-OH Product Crackdown

Florida 7-OH Crackdown

KCAC's Advocacy Buddy

Folder: Consumers

Back

GKC For Consumers

The Evolution of Leaf Kratom Infographic

Folder: Business

Back

Marketing Guidelines

Florida FAQ Flyer

Regulatory Label Requirement

Novel Synthetic Alkaloid Database

Back

Sign Up To Our Email List

Folder: Health & Science

Back

AHP Botanical Safety Handbook

Scientists' Statement

Safety

Relative Safety/Risk Report: Kratom vs. Other Substances

GKC Statement on 7-Hydroxymitragynine Products

Scientists Statement on 7-OH MGPI Products

SUD Report: Prevalence, Severity and Symptom Endorsement

The Severity and Prevalence of Addictive Substances

Kratom Alkaloids

FDA Study on Kratom Dosing and Safety

National Marketing Institute (NMI) Kratom Survey

UCONN Continuing Education Program

"7" Fact vs. Fiction

Eight-Factor Analysis of Natural Kratom Leaf

Rise in Poison Center Calls are From Concentrated 7-OH: Data

North Dakota Poison Control Data 2021-2025

18 Human Clinical Trials

Kratom Science Is Accelerating. Fast.

Dr. Andrew Huberman - The Distinction

Kratom in Clinical Practice

Back

Back

KCAC Position Statements

KCAC In The News

UConn Pharmacy Research on Kratom and Substances of Abuse

KCAC 2025 Impact Snapshot

Eight-Factor Analysis of Natural Kratom Leaf

Share the PDF

Novel Synthetic Alkaloids vs. Natural Kratom Leaf

DOWNLOAD

2026 Global Kratom Coalition™